Heteroarylalkoxy-substituted quinolone inhibitors of PDE4
US8138205B2 · kind B2 · utility
1Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 2009 |
| Grant date | Mar 20, 2012 |
| Priority date | — |
| Expiry date | Nov 17, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds and methods which may be useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.